Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis C
Keyword(s):
2013 ◽
Vol 20
(1)
◽
pp. 35
◽
Keyword(s):
Keyword(s):
2011 ◽
Vol 56
(8)
◽
pp. 2449-2455
◽
Keyword(s):
Keyword(s):